A Stock Analysis: Buy, Sell, or Hold?
A - Agilent Technologies Inc.
$133.85
0.58 (0.44%)
▲
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 25, 2026
24d
Get Alerted When A Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: A shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: A shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$208.74
Based on 7.2% avg growth
INTRINSIC VALUE TODAY
$129.61
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 22.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: A is currently trading at $133.85, which is considered oversold relative to its 30-day fair value range of $135.22 to $144.93. The stock's valuation (Forward PE: 20.4) is in line with its historical norms (22.6). Remarkably, the market is currently pricing in an annual earnings decline of 3.4% over the next few years. This pessimistic expectation contrasts with the company's recent 24.5% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, A is in a uptrend. Immediate support is located at $129.63, while resistance sits at $144.88.
Market Sentiment: A has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $169.67 (+27.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, A is in a uptrend. Immediate support is located at $129.63, while resistance sits at $144.88.
Market Sentiment: A has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $169.67 (+27.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$135.22 -
$144.93
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
Protect Your Profits
Holding A? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 27.3% below Wall St target ($169.67)
Fair Price Analysis
30-Day Fair Range
$135.22 -
$144.93
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$129.63
Resistance Level
$144.88
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
20.36
Wall Street Target
$169.67
(+27.3%)
Revenue Growth (YoY)
9.4%
Earnings Growth (YoY)
24.5%
Profit Margin
18.8%
Valuation Discount vs History
-3.4% cheaper
PE vs Historical
20.4 vs 22.6
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-3.4%
(market-implied from PE analysis)
1-Year Target
$128.74
(-3%)
2-Year Target
$124.36
(-7%)
3-Year Target
$120.13
(-10%)
3-Yr Target (if PE normalizes)
(PE: 20→23)
$133.37
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: 10.3%)
$196.00
(+47%)
Base:
(SPY PE: 20.4, Growth: 10.3%)
$178.93
(+34%)
Bear:
(PE: 17.3, Growth: 10.3%)
$152.09
(+14%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (29x PE), but valuation improves significantly next year (20x PE) as earnings recover.
Trailing PE: 29.29 | Current EPS (TTM): $4.57
Bull Case
$210.94
(+58%)
Analyst growth 43.2%, PE expands to 32.2
Base Case
$191.77
(+43%)
Market implied 43.2%, PE stable at 29.3
Bear Case
$91.03
(-32%)
Severe decline -20.0%, PE contracts to 24.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 20.4 to 22.6
Stabilization Target:
$147.95
(+11.0%)
PE Expansion Potential:
+11.0%
Last updated: January 31, 2026 1:45 AM ET
Data refreshes hourly during market hours. Next update: 2:45 AM
Data refreshes hourly during market hours. Next update: 2:45 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is A showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
NEUTRAL
Recent Transactions
Ro Khanna
BUY
2025-09-29
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$653 | 47 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 57 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$121 | 62 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$263 | 47 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$257 | 58 HOLD |
Advanced A Option Strategies
Professional options setups generated by AI based on today's A price and gamma walls.
